RT Journal Article
SR Electronic
T1 Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.23.20248425
DO 10.1101/2020.12.23.20248425
A1 Lloréns-Rico, Verónica
A1 Gregory, Ann C.
A1 Van Weyenbergh, Johan
A1 Jansen, Sander
A1 Van Buyten, Tina
A1 Qian, Junbin
A1 Braz, Marcos
A1 Menezes, Soraya Maria
A1 Van Mol, Pierre
A1 Vanderbeke, Lore
A1 Dooms, Christophe
A1 Gunst, Jan
A1 Hermans, Greet
A1 Meersseman, Philippe
A1 CONTAGIOUS collaborators
A1 Wauters, Els
A1 Neyts, Johan
A1 Lambrechts, Diether
A1 Wauters, Joost
A1 Raes, Jeroen
YR 2021
UL http://medrxiv.org/content/early/2021/06/24/2020.12.23.20248425.abstract
AB Understanding the pathology of COVID-19 is a global research priority. Early evidence suggests that the respiratory microbiome may be playing a role in disease progression, yet current studies report contradictory results. Here, we examine potential confounders in COVID-19 respiratory microbiome studies by analyzing the upper (n=58) and lower (n=35) respiratory tract microbiome in well-phenotyped COVID-19 patients and controls combining microbiome sequencing, viral load determination, and immunoprofiling. We found that time in the intensive care unit and the type of oxygen support, both of which are associated to additional treatments such as antibiotic usage, explained the most variation within the upper respiratory tract microbiome, while SARS-CoV-2 viral load had a reduced impact. Specifically, mechanical ventilation was linked to altered community structure, lower species- and higher strain-level diversity, and significant shifts in oral taxa previously associated with COVID-19. Single-cell transcriptomic analysis of the lower respiratory tract of mechanically ventilated COVID-19 patients identified specific oral bacteria, different to those observed in controls. These oral taxa were found physically associated with proinflammatory immune cells, which showed higher levels of inflammatory markers. Overall, our findings suggest confounders are driving contradictory results in current COVID-19 microbiome studies and careful attention needs to be paid to ICU stay and type of oxygen support, as bacteria favored in these conditions may contribute to the inflammatory phenotypes observed in severe COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04327570Clinical Protocols https://clinicaltrials.gov/ct2/show/NCT04327570 Funding StatementThis study has been supported by funding from the VIB Grand Challenges Program. VLR is supported by an FWO senior postdoctoral fellowship (12V9421N). ACG is supported by an EMBO postdoctoral fellowship (ALTF 349-2019). The Raes lab is supported by KU Leuven, the Rega institute and VIB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the Ethics Commission at UZ Leuven hospitalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw amplicon sequencing data that support the findings of this study have been deposited at the European Genome-phenome Archive (EGA), with accession no EGAS00001004951. The single cell RNA-seq data was first described in a separate publication and deposited also in EGA with accession number EGAS00001004717.